Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
CANC
51
HOLDINGS
22%
ALSO IN IDNA
IDNA
44
HOLDINGS
29%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 6.5% | 4.2% | 4.2% |
 |
ASTRAZENECA PLC | 3.9% | 3.9% | 3.9% |
|
ARCELLX, INC. | 3.9% | 4.6% | 3.9% |
|
EXELIXIS INC | 3.0% | 3.5% | 3.0% |
|
IMMUNOME, INC. | 2.5% | 2.0% | 2.0% |
CANC Overweight Relative to IDNA
|
ELI LILLY & CO | 4.8% |
 |
GENMAB A/S SPONSORED ADR | 4.8% |
|
BRIDGEBIO PHARMA, INC. | 4.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% |
|
NOVARTIS AG | 4.3% |
 |
MERUS N.V. | 4.0% |
|
NUVALENT, INC. CLASS A | 3.5% |
|
ABBVIE INC | 3.0% |
|
BEIGENE LTD. SPONSORED ADR | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
CANC Underweight Relative to IDNA
|
GENMAB A/S | -5.1% |
|
INCYTE CORP | -4.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -3.9% |
|
ROCHE HOLDING LTD | -3.8% |
|
GSK PLC | -3.8% |
 |
SANOFI-AVENTIS | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.5% |
|
MODERNA, INC. | -3.5% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
|
REGENERON PHARMACEUTICALS | -3.1% |